The effect of iodine prophylaxis on the frequency of thyroiditis and thyroid tumors in Southwest, Iran

Saudi Medical Journal

Volumn 28, Issue 7, 2007, Pages 1034-1038

  Soveid, Mahmood ^a   Monabbati, Ahmad ^b   Sooratchi, Leyla ^c   Dahti, Sara ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; IODIZED SALT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IODINATION; IRAN; LYMPHOCYTIC INFILTRATION; MALE; REPEAT PROCEDURE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; THYROID TUMOR; THYROIDITIS; COMPARATIVE STUDY; PAPILLARY CARCINOMA; PATHOLOGY; SALT INTAKE; THYROIDECTOMY;

ADULT; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IODINE; IRAN; MALE; SODIUM CHLORIDE, DIETARY; THYROID NEOPLASMS; THYROIDECTOMY; THYROIDITIS;

EID: 34548458459     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Delange F. Risk and benefits of iodine supplementation. Lancet 1998; 351: 923-924.
2. Sundick RS, Bagchi N, Brown TR. The role of iodine in thyroid autoimmunity: From chickens to humans: A review. Autoimmunity 1992; 13: 61-68.
3. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335: 99-107.
4. Harach HR, Escalante DA. Day ES. Thyroid cancer and thyroiditis in Salta, Argentina: A 40-y study in relation to iodine prophylaxis. Endocr Pathol 2002; 13: 175-181.
5. Hofstadter F. Frequency and morphology of malignant tumours of the thyroid before and after the introduction of iodine prophylaxis. Virchows Archiv A Pathol Anat Histol 1980; 385: 263-270.
6. Azizi F, Kimiagar M, Nafarabadi M. Yassai M. Current status of iodine deficiency in the Islamic Republic of Iran. EMR Health Ser J 1990; 8: 23-27.
7. Azizi F, Sheikholeslam R. Hedayati M, Mirmiran P, Malekafzali H, Kimiagar M, et at Sustainable control of iodine deficiency in Iran: Beneficial results of the implementation of the mandatory law on salt iodization. J Endocrinol Invest 2002; 25: 409-413.
8. Williams ED, Doniach I. The post mortem incidence of focal thyroiditis. J Pathol Bacteriol 1962; 83: 255-265.
9. Bourdoux pp, Ermans AM, Mukalay wa Mukalay A, Filetti S. Vigneri R. Iodine induced thyrotoxicosis in Kivu, Zaire letter]. Lancet 1996; 347: 552-553.
10. Harach HR, Williams ED. Thyroid cancer and thyroiditis in goiterous region of Salta, Argentina, before and after iodine prophylaxis. Clin Endocrinol (Oxt) 1995; 43: 701-706.
11. Roti E, Montermini M, Robuschi G, Gardini E, Salvo D, Gionet M, et al. Prevalence of hypothyroidism and Hashimoto thyroiditis in two elder1y populations with different iodine intake. In: Pinchera A, Ingbar SH, McKenzi JM, Fenzi GF, editors. Thyroid Autoimmunity. New York: Plenum Press; 1987. p.555-557.
12. Kahaly GJ, Dienes HP. Beyer J, Hommel G. Iodide induces thyroid autoimmunity in patients with endemic goiter. a randomized, double-blind, placebo controlled trial. Eur J Endocrino 1998; 139: 290-297.
13. Boukis MA, Koutras DA, Souvatzoglou A, Evangelopoulo A, Vrontakis M, Moulopoulos SD. Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab 1983; 57: 859-862.
14. Sundick RS, Herdegen DM, Brown TR, Bagchi N. The incorporation of dietary iodine into thyroglobulin increases its immunogenicity. Endocrinology 1987; 120: 2078-2084.
15. Bagchi N, Sundick RS, Hu LH. Cumming GD, Brown TR. Distinct regions of thyroglobulin control the proliferation and suppression of thyroid specific lymphocytes in obese strain chickens. Endocrinology 1996; 137: 3286-3290.
16. Bagchi N, Brown TR, Herdegen DM, Dhar A, Sundick RS. Antioxidants delay the onset of thyroiditis in obese strain chickens. Endocrinology 1990; 127: 1590-1595.
17. Weetman AP, McGregor AM, Campbell H. Lazarus JH, Ibbertson HK, Hall R. Iodide enhances IgG synthesis by human peripheral blood lymphocytes in vitro. Acta Endocrinol (Copenh) 1983; 103: 210-215.
18. Sztankay A, Trieb K. Lucciarini P, Steiner E, Grubeck - Loebenstein B. Interferon gamma and iodide increase the inducibility of the 72 kD heat shock protein in cultured human thyroid epithelial cells. J Autoimmun 1994; 7: 219-230.
19. Knobel M, Medeiros-Neto G. Iodized oil treatment for endemic goiter does not induce the surge of positive serum concentrations of antithyroglobulin or anti-microsomal autoantibodies. J Endocrinol Invest 1986; 9: 321-324.
20. Eltom M, Kar1sson FA, Kamal AM, Bostrom H, Dahlberg PA. The effectiveness of oral iodized oil in the traatment and prophylaxis of endemic goiter. J Clin Endocrinol Metab 1985; 61: 1112-1117.
21. Lazarus JH, Parkes AB, John R, N'Diaye M, Prysor-Jones SG. Endemic goitre in Senegal-thyroid function etiological factors and treatment with oral iodized oil. Acta Endocrinol (Copenh) 1992; 126: 149-154.
22. Tonglet R, Bourdoux P, Minga T, Ermans AM. Efficacy of low oral doses of iodized oil in the control of iodine deficiency in Zaire. N Engl J Med 1992; 326: 236-241.
23. Cohen SB, Weetman AP. The effect of iodide depletion and supplementation in the Buffalo strain rat. J Endocrinol Invest 1988; 11: 625-627.
24. Okayasu I, Fujiwara M. Hara Y, Tanaka Y, Rose NR. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 1995; 76: 2312-2318.
25. Gartner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurrn MW. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibody concentrations. J Clin Endocrinol Metab 2002; 87: 1687-1691.
26. Monteiro E, Galvao-Teles A, Santos ML, Mourao L, Correia MJ, Lopo Tuna J, et al. Antithyroid antibodies as an early mar1
27. Weetman AP, Bhandal SK, Burrin JM, Robinson K, McKenna W. Amiodarone and thyroid autoimmunity in the United Kingdom. BMJ 1988; 297: 33.
28. Papanastasiou L, Alevizaki M, Piperingos G, Mantzos E. Tseleni-Balafouta S, Koutras DA. The effect of iodine administration on the development of thyroid autoimmunity in patients with non toxic goiter. Thyroid 2000; 10: 493497.
29. Williams ED, Doniach I, Bjamason O, Michie W. Thyroid cancer in iodine rich area. Cancer 1977; 39: 215-222.
30. Okayasu I, Hara Y. Nakamura K, Rose NR. Racial and age related differences in incidence and severity of focal autoimmune thyroiditis. Am J Clin Pathol 1994; 101: 698-702.
31. Tamimi DM. The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol 2002; 10: 141-146.
32. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 1999; 84: 458463.
33. Arif S, Blanes A, Diaz-Cano SJ. Hashimoto thyroiditis shares features with early papillary thyroid carcinoma. Histopathology 2002; 41: 357-362.